Skip to main content
. 2023 Jan 11;2(2):100076. doi: 10.1016/j.jacig.2022.10.007

Table III.

Reasons for discontinuation of the biologic treatment

Reason for discontinuation Prescriptions (n = 127)
Lost to follow-up or because of COVID-19 pandemic restrictions, no. (%) 41 (32.3)
Lack of response, no. (%) 39 (30.7)
Side effects, no. (%) 14 (11)
Patient preference, no. (%) 14 (11)
Inadequate insurance coverage, no. (%) 11 (8.7)
Noncompliance, no. (%) 8 (6.3)

Defined as the need for prednisone taper for treatment of asthma exacerbations while compliant with a biologic.